NASDAQ:ADMA

ADMA Biologics News Headlines

$1.71
-0.07 (-3.93 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.69
Now: $1.71
$1.79
50-Day Range
$1.67
MA: $2.06
$2.60
52-Week Range
$1.57
Now: $1.71
$4.20
Volume1.31 million shs
Average Volume3.58 million shs
Market Capitalization$207.38 million
P/E RatioN/A
Dividend YieldN/A
Beta1.84

Headlines

ADMA Biologics (NASDAQ ADMA) News Headlines Today

SourceHeadline
ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual MeetingADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting
finance.yahoo.com - April 13 at 12:40 PM
Hyperimmune Serum Market to Witness Huge Growth by 2026 | Grifols, Biotest, Kamada, ADMA BiologicsHyperimmune Serum Market to Witness Huge Growth by 2026 | Grifols, Biotest, Kamada, ADMA Biologics
marketwatch.com - April 10 at 12:55 AM
ADMA Biologics (NASDAQ:ADMA) Shareholders Are Down 74% On Their SharesADMA Biologics' (NASDAQ:ADMA) Shareholders Are Down 74% On Their Shares
nasdaq.com - April 7 at 4:40 AM
ADMA Biologics, Inc. (NASDAQ:ADMA) Receives Consensus Recommendation of "Buy" from BrokeragesADMA Biologics, Inc. (NASDAQ:ADMA) Receives Consensus Recommendation of "Buy" from Brokerages
americanbankingnews.com - April 5 at 9:20 AM
ADMA Biologics (NASDAQ:ADMA) Stock Rating Reaffirmed by Jefferies Financial GroupADMA Biologics (NASDAQ:ADMA) Stock Rating Reaffirmed by Jefferies Financial Group
americanbankingnews.com - April 5 at 8:42 AM
Raymond James Lowers ADMA Biologics (NASDAQ:ADMA) Price Target to $6.00Raymond James Lowers ADMA Biologics (NASDAQ:ADMA) Price Target to $6.00
americanbankingnews.com - April 1 at 9:34 AM
-$0.15 Earnings Per Share Expected for ADMA Biologics, Inc. (NASDAQ:ADMA) This Quarter-$0.15 Earnings Per Share Expected for ADMA Biologics, Inc. (NASDAQ:ADMA) This Quarter
americanbankingnews.com - March 29 at 10:46 AM
Analyzing ADMA Biologics (NASDAQ:ADMA) & Allena Pharmaceuticals (NASDAQ:ALNA)Analyzing ADMA Biologics (NASDAQ:ADMA) & Allena Pharmaceuticals (NASDAQ:ALNA)
americanbankingnews.com - March 28 at 6:38 AM
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q4 2020 Results - Earnings Call TranscriptADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 27 at 3:15 PM
ADMA Biologics (NASDAQ:ADMA) Receives Buy Rating from Maxim GroupADMA Biologics (NASDAQ:ADMA) Receives Buy Rating from Maxim Group
americanbankingnews.com - March 27 at 12:18 PM
ADMA Biologics (NASDAQ:ADMA) Posts Quarterly  Earnings Results, Misses Estimates By $0.03 EPSADMA Biologics (NASDAQ:ADMA) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS
americanbankingnews.com - March 26 at 9:28 AM
ADMA Biologics (NASDAQ:ADMA) Price Target Lowered to $6.00 at Raymond JamesADMA Biologics (NASDAQ:ADMA) Price Target Lowered to $6.00 at Raymond James
americanbankingnews.com - March 26 at 8:46 AM
Adma Biologics (ADMA) Reports Q4 Loss, Tops Revenue EstimatesAdma Biologics (ADMA) Reports Q4 Loss, Tops Revenue Estimates
finance.yahoo.com - March 25 at 10:58 PM
Adma Biologics: Q4 Earnings SnapshotAdma Biologics: Q4 Earnings Snapshot
finance.yahoo.com - March 25 at 5:58 PM
ADMA Biologics Q4 loss widensADMA Biologics Q4 loss widens
marketwatch.com - March 25 at 5:58 PM
ADMA Biologics Reports Fourth Quarter and Full Year 2020 Financial ResultsADMA Biologics Reports Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - March 25 at 5:58 PM
ADMA Biologics, Inc. Forecasted to Earn FY2025 Earnings of $0.57 Per Share (NASDAQ:ADMA)ADMA Biologics, Inc. Forecasted to Earn FY2025 Earnings of $0.57 Per Share (NASDAQ:ADMA)
americanbankingnews.com - March 24 at 9:20 AM
ADMA Biologics (NASDAQ:ADMA) and La Jolla Pharmaceutical (NASDAQ:LJPC) Financial ComparisonADMA Biologics (NASDAQ:ADMA) and La Jolla Pharmaceutical (NASDAQ:LJPC) Financial Comparison
americanbankingnews.com - March 20 at 4:10 PM
ADMA Biologics (ADMA) Scheduled to Post Quarterly Earnings on ThursdayADMA Biologics (ADMA) Scheduled to Post Quarterly Earnings on Thursday
americanbankingnews.com - March 19 at 10:37 AM
ADMA Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021ADMA Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021
finance.yahoo.com - March 18 at 8:36 AM
Adma Biologics (ADMA) May Report Negative Earnings: Know the Trend Ahead of Q4 ReleaseAdma Biologics (ADMA) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
finance.yahoo.com - March 4 at 3:11 PM
ADMA Biologics to Participate in the Jefferies Virtual Plasma SummitADMA Biologics to Participate in the Jefferies Virtual Plasma Summit
finance.yahoo.com - March 4 at 10:10 AM
ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma CollectionsADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma Collections
finance.yahoo.com - March 3 at 8:16 AM
ADMA Biologics Presents Late-Breaking Poster Presentation Highlighting Clinical Utility of S. Pneumoniae Hyperimmune Globulin at the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annual MeetingADMA Biologics Presents Late-Breaking Poster Presentation Highlighting Clinical Utility of S. Pneumoniae Hyperimmune Globulin at the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting
finance.yahoo.com - February 26 at 12:05 PM
Healthcare distribution market is expected to grow at a CAGR of around 7.7% over the forecast period 2019 to 2026Healthcare distribution market is expected to grow at a CAGR of around 7.7% over the forecast period 2019 to 2026
marketwatch.com - February 26 at 7:05 AM
Adma Biologics (ADMA) Upgraded to Buy: Heres WhyAdma Biologics (ADMA) Upgraded to Buy: Here's Why
msn.com - February 17 at 1:05 PM
Knoxville Biz Ticker: Celebrate National Pizza Day with a slice at Pilot Flying JKnoxville Biz Ticker: Celebrate National Pizza Day with a slice at Pilot Flying J
msn.com - February 5 at 5:03 PM
ADMA Biologics gets FDA approval for plasma collection facility in TennesseeADMA Biologics gets FDA approval for plasma collection facility in Tennessee
seekingalpha.com - February 4 at 8:49 PM
Knoxville Biz Ticker: ADMA Biologics receives FDA approval for ADMA BioCenters plasma collection facilityKnoxville Biz Ticker: ADMA Biologics receives FDA approval for ADMA BioCenters plasma collection facility
msn.com - February 2 at 3:12 PM
2 Small-Cap Biotechs That Show Promise in 20212 Small-Cap Biotechs That Show Promise in 2021
realmoney.thestreet.com - February 1 at 1:13 PM
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TNADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN
finance.yahoo.com - February 1 at 8:12 AM
ADMA Biologics IncADMA Biologics Inc
reuters.com - January 21 at 10:46 PM
ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2020 Revenues and Provides 2021 Strategic OutlookADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2020 Revenues and Provides 2021 Strategic Outlook
finance.yahoo.com - January 19 at 3:32 PM
Immunoglobulin Market - Industry Analysis and Forecast (2021-2030) | ADMA Biologics Inc, Shire plcImmunoglobulin Market - Industry Analysis and Forecast (2021-2030) | ADMA Biologics Inc, Shire plc
marketwatch.com - January 8 at 11:41 PM
ADMA Biologics Receives Unique Temporary C-Code and Pass-Through Payment Status for ASCENIV™ADMA Biologics Receives Unique Temporary C-Code and Pass-Through Payment Status for ASCENIV™
finance.yahoo.com - January 4 at 8:51 AM
ADMA Biologics, Inc. (NASDAQ:ADMA) Insiders Increased Their HoldingsADMA Biologics, Inc. (NASDAQ:ADMA) Insiders Increased Their Holdings
finance.yahoo.com - December 22 at 7:53 AM
Is ADMA A Good Stock To Buy According To Hedge Funds?Is ADMA A Good Stock To Buy According To Hedge Funds?
finance.yahoo.com - December 19 at 3:12 PM
ADMA Biologics Adopts Limited Duration Stockholder Rights PlanADMA Biologics Adopts Limited Duration Stockholder Rights Plan
finance.yahoo.com - December 16 at 5:52 PM
ADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive AdvisorsADMA Biologics Enters Into $100 Million Credit Facility Loan Amendment with Perceptive Advisors
finance.yahoo.com - December 9 at 9:19 AM
Outlook on the Plasma Fractionation Global Market to 2025 - Featuring ADMA Biologics, Baxter and China Biologic Products Among OthersOutlook on the Plasma Fractionation Global Market to 2025 - Featuring ADMA Biologics, Baxter and China Biologic Products Among Others
benzinga.com - December 4 at 10:58 AM
ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Maryville, TNADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Maryville, TN
finance.yahoo.com - December 1 at 7:34 AM
ADMA Biologics: Another Quarter Of Progress And Another Dip To BuyADMA Biologics: Another Quarter Of Progress And Another Dip To Buy
seekingalpha.com - November 11 at 11:31 PM
ADMA Biologics to Participate in Jefferies 2020 Virtual London Healthcare ConferenceADMA Biologics to Participate in Jefferies 2020 Virtual London Healthcare Conference
finance.yahoo.com - November 10 at 10:06 AM
Analysts Have Lowered Expectations For ADMA Biologics, Inc. (NASDAQ:ADMA) After Its Latest ResultsAnalysts Have Lowered Expectations For ADMA Biologics, Inc. (NASDAQ:ADMA) After Its Latest Results
nasdaq.com - November 7 at 7:49 AM
ADMA Biologics, Inc. (NASDAQ:ADMA) Analysts Are Cutting Their Estimates: Heres What You Need To KnowADMA Biologics, Inc. (NASDAQ:ADMA) Analysts Are Cutting Their Estimates: Here's What You Need To Know
finance.yahoo.com - November 7 at 7:49 AM
ADMA Biologics Inc (ADMA) Q3 2020 Earnings Call TranscriptADMA Biologics Inc (ADMA) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 6 at 2:54 PM
Adma Biologics (ADMA) Reports Q3 Loss, Tops Revenue EstimatesAdma Biologics (ADMA) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 5 at 11:38 PM
ADMA Biologics Reports Third Quarter 2020 Financial Results and Business HighlightsADMA Biologics Reports Third Quarter 2020 Financial Results and Business Highlights
finance.yahoo.com - November 5 at 6:38 PM
CGEN Nov 2020 2.500 callCGEN Nov 2020 2.500 call
uk.finance.yahoo.com - October 30 at 6:53 PM
ADMA Biologics to Report Third Quarter 2020 Financial Results and Business Highlights on November 5, 2020ADMA Biologics to Report Third Quarter 2020 Financial Results and Business Highlights on November 5, 2020
finance.yahoo.com - October 29 at 8:54 AM
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.